Lauflumide

N/A

Report date: 2024/02/05 16:46:23

Base Information

Drug NameLauflumide
Drug Alias NameNLS-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitors
TargetsDopamine transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityAlzheimer DiseaseFatigue Syndrome, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNls Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNLS Pharmaceutics Ltd
Inactive CompaniesNls Pharma
Active IndicationsFatigue Syndrome, Chronic
Inactive IndicationsAttention Deficit Disorder with HyperactivityAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipedia